Finance

Lists
IMDX:NASDAQ
Insight Molecular Diagnostics Inc
$3.92
-5.08%
(-0.21) 1D
Aug 31, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMDX...
Open
$4.10
High
$4.12
Low
$3.88
Mkt. cap
128.28M
Avg. vol.
174.36K
Volume
102.40K
52-wk high
$8.51
52-wk low
$2.40
EPS
-$1.48
Beta
1.79
Shares outstanding
32.72M
No. of employees
57
Open
$4.10
High
$4.12
Low
$3.88
Mkt. cap
128.28M
Avg. vol.
174.36K
Volume
102.40K
52-wk high
$8.51
52-wk low
$2.40
EPS
-$1.48
Beta
1.79
Shares outstanding
32.72M
No. of employees
57
About Insight Molecular Diagnostics Inc
CEO-
Employees57
Founded2009
HeadquartersNashville, Tennessee, United States
SectorBiotechnology
Websiteimdxinc.com
Analyst ratings
Based on 4 analysts giving stock ratings to IMDX in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IMDX in the last 3 months.
Highest
Current $3.92
$12.00 (+206.12%)
Average
$9.67 (+146.68%)
Lowest
$8.00 (+104.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alexander Nowak
Lucid Capital
Buy
Initiated
$8.00
+104.1%
08/24/2026
Thomas Flaten
Lake Street
Buy
Maintained
$12.00
+206.1%
08/18/2026
Michael Matson
Needham
Buy
Reiterated
$9.00
+129.6%
08/18/2026
Mark Massaro
BTIG
Hold
Reiterated
-
-
08/18/2026
Ben Haynor
Lake Street
Buy
Reiterated
$12.00
+206.1%
04/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
260.00K
1.14M
32.00K
239.00K
Cost of goods sold
121.00K
643.00K
17.00K
82.00K
Cost of revenue
121.00K
643.00K
17.00K
82.00K
Research and development expenses
3.88M
5.83M
4.95M
4.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.93M
4.62M
5.39M
4.79M
Operating expense
7.81M
10.45M
10.35M
9.28M
Total operating expenses
7.93M
11.09M
10.36M
9.36M
Operating income
-7.67M
-9.95M
-10.33M
-9.12M
Other non operating income
223.00K
506.00K
146.00K
162.00K
EBT including unusual items
-10.85M
-22.96M
-4.29M
-11.26M
EBT excluding unusual items
-7.48M
-9.47M
-10.21M
-8.98M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.85M
-22.96M
-4.29M
-11.26M
Net profit margin
-4,174.62%
-2,015.36%
-13,406.25%
-4,711.30%
Earnings per share
-0.23
-0.30
-
-0.24
Interest and investment income
-
-
-
-
Interest expense
-29.00K
-26.00K
-23.00K
-20.00K
Net interest expenses
-29.00K
-26.00K
-23.00K
-20.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.09M
-9.39M
-9.70M
-8.45M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps